机器学习可以检测癌症的SINEs
Christopher Douville1,2,3,4,5, Kamel Lahouel6,7,8,9, Albert Kuo2,4,5,9
1Division of Quantitative Sciences, Johns Hopkins University School of Medicine, 733 N. Broadway, Baltimore, MD 21205, USA.
Science translational medicine
|January 24, 2024
概括
一种新的机器学习方法,Alu Profile Learning Using Sequencing (A-PLUS),分析循环中的DNA以检测固体癌症. 这种专注于Alu元素的方法显示出早期癌症检测和提高查性能的前景.
科学领域:
- 基因组学就是基因组学.
- 生物标志物 生物标志物
- 机器学习 机器学习
背景情况:
- 之前,RealSeqS 已经使用了约35万个重复元素,在无细胞DNA中启用了状体的评估.
- 假设对RealSeqS数据的公正分析可以识别其他与癌症相关的差异.
研究的目的:
- 开发和应用一种机器学习方法 (A-PLUS) 来分析用于癌症检测的无血细胞DNA.
- 研究癌症患者和健康个体之间循环DNA概况的差异.
主要方法:
- 开发了一种机器学习模型Alu Profile Learning Using Sequencing (A-PLUS),它是使用测序进行学习的.
- 为训练,验证和可重复性,在四个队列中对7615个样本 (2073个癌症) 进行了A-PLUS的应用.
- 集成的A-PLUS与动脉化和蛋白质生物标志物进行增强检测.
主要成果:
- 在验证队列中,A-PLUS在11种癌症类型中获得了40.5%的灵敏度和98.5%的特异性.
- 综合方法检测到51%的癌症,具有98.9%的特异性.
- 在癌症患者的循环DNA中发现了Alus元素的全球减少,全基因组测序证实了这一点.
结论:
- 使用测序 (A-PLUS) 的Alu Profile学习表明了早期癌症检测的潜力.
- 在循环DNA中减少Alu元素是癌症识别的关键特征.
- 评估Alu元素可能会提高现有的癌症检测方法的性能.
更多相关视频
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.2K
08:20Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
Published on: October 27, 2023
1.5K
相关概念视频
Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
